These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Safety and efficacy of bivalirudin with and without glycoprotein IIb/IIIa inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention 1-year results from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial. White HD, Ohman EM, Lincoff AM, Bertrand ME, Colombo A, McLaurin BT, Cox DA, Pocock SJ, Ware JA, Manoukian SV, Lansky AJ, Mehran R, Moses JW, Stone GW. J Am Coll Cardiol; 2008 Sep 02; 52(10):807-14. PubMed ID: 18755342 [Abstract] [Full Text] [Related]
39. Bivalirudin in PCI: an overview of the REPLACE-2 trial. Maroo A, Lincoff AM. Semin Thromb Hemost; 2004 Jun 05; 30(3):329-36. PubMed ID: 15282655 [Abstract] [Full Text] [Related]
40. Effectiveness and safety of bivalirudin during percutaneous coronary intervention in a single medical center. Gurm HS, Rajagopal V, Fathi R, Vivekanathan D, Yadav JS, Bhatt DL, Ellis SG, Lincoff AM, Topol EJ. Am J Cardiol; 2005 Mar 15; 95(6):716-21. PubMed ID: 15757596 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]